JW Pharmaceutical Total Liabilities

The latest total liabilities for 001067.KS is $250B as of June 2026. That compares with $270B in the prior-year period — down 6.3% year over year. Investors often review this figure alongside JW Pharmaceutical's historical trend and sector peers before judging valuation or financial health.

Over the past year, 001067.KS's total liabilities moved from $270B to $250B — a 6.3% year-over-year decrease. If the trend continues in the same direction for several quarters, it can signal a meaningful shift in JW Pharmaceutical's operating scale or balance-sheet position.

A total liabilities figure of $250B for 001067.KS is a snapshot of scale on that line item. On its own it does not say whether the business is healthy — you also want growth rate, margins, and how the number compares with similar companies. Explore the charts below for those layers of context.

After noting 001067.KS's total liabilities ($250B), review year-over-year change from $270B, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.